Biering-Sørensen Tor, Biering-Sørensen Sofie Reumert, Olsen Flemming Javier, Sengeløv Morten, Jørgensen Peter Godsk, Mogelvang Rasmus, Shah Amil M, Jensen Jan Skov
From the Department of Cardiology, Herlev and Gentofte Hospital (T.B.-S., S.R.B.-S., F.J.O., M.S., P.G.J., R.M., J.S.J.), The Copenhagen City Heart Study, Frederiksberg Hospital (T.B.-S., S.R.B.-S., P.G.J., R.M., J.S.J.), and Institute of Clinical Medicine, Faculty of Health Sciences (J.S.J.), University of Copenhagen, Denmark; and Department of Medicine, Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (T.B.-S., A.M.S.).
Circ Cardiovasc Imaging. 2017 Mar;10(3). doi: 10.1161/CIRCIMAGING.116.005521.
Global longitudinal strain (GLS) is prognostic of adverse cardiovascular outcomes in various patient populations, but the prognostic utility of GLS for long-term cardiovascular morbidity and mortality in the general population is unknown.
A total of 1296 participants in a general population study underwent a health examination, including echocardiography measurement of GLS. The primary end point was the composite of incident heart failure, acute myocardial infarction, or cardiovascular death. During a median follow-up of 11 years, 149 (12%) participants were diagnosed with heart failure, acute myocardial infarction, or cardiovascular death. Lower GLS was associated with a higher risk of the composite end point (hazard ratio, 1.12; 95% confidence interval, 1.08-1.17; <0.001 per 1% decrease), an association that persisted after multivariable adjustment for age, sex, heart rate, hypertension, systolic blood pressure, left ventricular ejection fraction, left ventricular mass index, left ventricular dimension, deceleration time, left atrium dimension, /', and pro B-type natriuretic peptide (hazard ratio, 1.05; 95% confidence interval, 1.00-1.11; =0.045 per 1% decrease). GLS provided incremental prognostic information beyond the Framingham Risk Score, the Systemic Coronary Evaluation risk chart, and the modified American College of Cardiology/American Heart Association Pooled Cohort Equation for the composite outcome and incident heart failure. Sex modified the relationship between GLS and outcome such that after multivariable adjustment, GLS was an independent predictor of outcomes in men but not in women (hazard ratio, 1.14; 95% confidence interval, 1.06-1.24; =0.001, and hazard ratio, 0.99; 95% confidence interval, 0.92-1.07; =0.81, respectively; for interaction =0.032).
In the general population, GLS provides independent and incremental prognostic information regarding long-term risk of cardiovascular morbidity and mortality. GLS seems to be a stronger prognosticator in men than in women.
整体纵向应变(GLS)可预测不同患者群体的不良心血管结局,但GLS对一般人群长期心血管发病率和死亡率的预测效用尚不清楚。
一项针对一般人群的研究共纳入1296名参与者,他们接受了包括GLS超声心动图测量在内的健康检查。主要终点是新发心力衰竭、急性心肌梗死或心血管死亡的复合终点。在中位随访11年期间,149名(12%)参与者被诊断患有心力衰竭、急性心肌梗死或心血管死亡。较低的GLS与复合终点风险较高相关(风险比,1.12;95%置信区间,1.08 - 1.17;每降低1%,<0.001),在对年龄、性别、心率、高血压、收缩压、左心室射血分数、左心室质量指数、左心室维度、减速时间、左心房维度和B型利钠肽原进行多变量调整后,这种关联仍然存在(风险比,1.05;95%置信区间,1.00 - 1.11;每降低1%,=0.045)。对于复合结局和新发心力衰竭,GLS提供了超出弗雷明汉风险评分、系统性冠状动脉评估风险图以及改良的美国心脏病学会/美国心脏协会汇总队列方程的增量预后信息。性别改变了GLS与结局之间的关系,多变量调整后,GLS是男性结局的独立预测因子,但不是女性结局的独立预测因子(风险比分别为1.14;95%置信区间,1.06 - 1.24;=0.001,以及风险比0.99;95%置信区间,0.92 - 1.07;=0.81;交互作用=0.032)。
在一般人群中,GLS提供了关于心血管发病率和死亡率长期风险的独立且增量的预后信息。GLS在男性中似乎比在女性中是更强的预后指标。